Elevated serum amyloid A is associated with venous thromboembolism

Thrombosis and Haemostasis

Volumn 109, Issue 2, 2013, Pages 358-359

  Deguchi, Hiroshi ^a   Elias, Darlene J ^a   Navarro, Silvia ^a,b   España, Francisco ^b   Griffin, John H ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID A PROTEIN; C REACTIVE PROTEIN;

ACUTE PHASE RESPONSE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INFLAMMATION; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; VENOUS THROMBOEMBOLISM;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SERUM AMYLOID A PROTEIN; UP-REGULATION; VENOUS THROMBOEMBOLISM;

EID: 84874753751     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH12-10-0722     Document Type: Letter

References (20)

1. Johnson BD, Kip KE, Marroquin OC, et al. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 2004; 109: 726-732.
2. Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Eng J Med 2000; 342: 836-843.
3. Ageno W, Becattini C, Brighton T, et al. Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation 2008; 117: 93-102.
4. Dentali F, Squizzato A, Ageno W. The metabolic syndrome as a risk factor for venous and arterial thrombosis. Semin Thromb Hemost 2009; 35: 451-457.
5. Di Minno MN, Tufano A, Ageno W, et al. Identifying high-risk individuals for cardiovascular disease: similarities between venous and arterial thrombosis in perspective. A 2011 update. Intern Emerg Med 2012; 7: 9-13.
6. Rodriguez AL, Wojcik BM, Wrobleski SK, et al. Statins, inflammation and deep vein thrombosis: a systematic review. J Thromb Thrombolysis 2012; 33: 371-382.
7. Fox EA, Kahn SR. The relationship between inflammation and venous thrombosis. A systematic review of clinical studies. Thromb Haemost 2005; 94: 362-365.
8. Zacho J, Tybjaerg-Hansen A, Nordestgaard BG. C-reactive protein and risk of venous thromboembolism in the general population. Arterioscler Thromb Vasc Biol 2010; 30: 1672-1678.
9. Gabay C, Kushner I. Mechanisms of disease: acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-454.
10. Takata S, Wada H, Tamura M, et al. Kinetics of c-reactive protein (CRP) and serum amyloid A protein (SAA) in patients with community-acquired pneumonia (CAP), as presented with biologic half-life times. Biomarkers 2011;16: 530-535.
11. van Rooijen M, Hansson LO, Frostegård J, et al. Treatment with combined oral contraceptives induces a rise in serum C-reactive protein in the absence of a general inflammatory response. J Thromb Haemost 2006; 4: 77-82.
12. Jylhävä J, Haarala A, Eklund C, et al. Serum amyloid A is independently associated with metabolic risk factors but not with early atherosclerosis: the Cardiovascular Risk in Young Finns Study. J Intern Med 2009; 266: 286-295.
13. Kumon Y, Suehiro T, Itahara T, et al. Serum amyloid A protein in patients with non-insulin-dependent diabetes mellitus. Clin Biochem 1994; 27: 469-473.
14. He R, Sang H, Ye RD. Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R. Blood 2003; 101: 1572-1581.
15. Lee MS, Yoo SA, Cho CS, et al. Serum amyloid A binding to formyl peptide receptor-like 1 induces synovial hyperplasia and angiogenesis. J Immunol 2006; 177: 5585-5594.
16. Cai H, Song C, Endoh I, et al. Serum amyloid A induces monocyte tissue factor. J Immunol 2007; 178: 1852-1860.
17. Zhao Y, Zhou S, Heng CK. Impact of serum amyloid A on tissue factor and tissue factor pathway inhibitor expression and activity in endothelial cells. Arterioscler Thromb Vasc Biol 2007; 27: 1645-1650.
18. Ames PRJ, Antinolfi I, Ciampa A, et al. Primary antiphospholipid syndrome: a low-grade auto-inflammatory disease? Rheumatology 2008; 47: 1832-1837.
19. Deguchi H, Pecheniuk NM, Elias DJ, et al. High density lipoprotein deficiency and dyslipoproteinemia associated with venous thrombosis in men. Circulation 2005; 112: 893-899.
20. Pecheniuk NM, Elias DJ, Deguchi H, et al. Elevated plasma fibronectin levels associated with venous thromboembolism. Thromb Haemost 2008; 100: 224-228.